NEET 2024 Answer Key To Release Soon, Here’s How to Check

New Delhi- After giving the National Eligibility cum Entrance Test for Undergraduate (NEET-UG) exam 2024, candidates are eagerly waiting for their results and the National Testing Agency (NTA) is soon going to release the provisional answer key of the NEET-UG exam 2024 on its official website. These provisional answer keys will help the students to check their answers with the correct answers provided.

NEET UG Answer Key serves as a valuable resource for medical aspirants who have appeared for the NEET-UG exam 2024. This helps them evaluate their performance in the exam and estimate their potential score. By comparing their answers with the answer key, students can identify any mistakes they may have made during the exam. This includes errors in understanding questions, calculation mistakes, or misinterpretation of concepts.

Along with the NEET answer key 2024, NTA will also release the NEET OMR response sheet of the candidates.

STEPS TO DOWNLOAD THE NEET UG 2024 ANSWER KEY

STEP 1- Visit the Exam NTA official website.

STEP 2- On the homepage, click on the link that reads, “Click Here for Answer Key” or “Download Answer Key.”

STEP 3- A new window will open, enter your login details such as Application Number and Date of Birth.

STEP 4- The NEET UG 2024 Answer Key will be displayed on the screen.

STEP 5- Download the provisional answer key and get its printout for further use.

The National Testing Agency conducted the National Eligibility-cum-Entrance Test [(NEET (UG)] – 2024 on 05 May 2024 from 02:00 P.M. to 05:20 P.M. throughout the country and 14 cities outside India in Pen & paper (offline) mode. The NEET UG 2024 saw record-high registrations this year, with over 24 lakh students registering, the highest ever, with over 10 lakh male students, and over 13 lakh female students.

Powered by WPeMatico

Health Bulletin 14/ May/ 2024

Here are the top health news for the day:

NEET candidates paid up to Rs 50 lakhs for getting question papers in advance

The brokers involved in the NEET paper leak scam took between Rs 30 lakh to Rs 50 lakh from each of the medical aspirants in exchange of giving them the question paper of the National Eligibility-cum-Entrance Test Undergraduate (NEET-UG) 2024 ahead of the examination on May 5th, 2024, the Economic Offences Unit (EOU) of Bihar Police has revealed.

EOU has seized several documents, including bank cheques, roll codes of candidates and other papers from the flats of Nitish Kumar and Amit Anand, who were arrested by the Patna Police on May 5.
For more information click on the link below:
Maharashtra records 91 cases of new Covid subvariant ‘FLiRT’
The Maharashtra government has identified 91 cases of the new Covid-19 Omicron subvariant KP.2, surpassing the previously dominant JN.1 variant as the main contributor to cases in several countries. Pune has reported the highest incidence with 51 cases, followed by Thane with 20 cases. Despite the increase in cases, there has been no rise in hospitalizations or severe cases.
In addition to Pune and Thane, Amravati and Aurangabad each reported seven cases, while Solapur recorded two cases, and Ahmednagar, Nashik, Latur, and Sangli each reported one case of the KP.2 variant. Mumbai reported no cases. The FLiRT group of variants, primarily comprising KP.1.1 and KP.2, are named for specific mutations they carry. KP.2, first identified globally in January, is now the dominant strain in the United States.
More than 37,000 medicos respond to NMC survey, confirm suffering from mental health issues
The shocking picture concerning the mental health of medical students has come to light as more than 37,000 medical students have submitted applications before the government authority, indicating that they are suffering from mental stress, Live Mint has reported.
Taking cognisance of this, the apex medical education authority has prescribed several measures including regulating the duty hours of the students and initiating a suicide watch. These recommendations by the National Medical Commission (NMC) will be submitted before the Union Health Ministry for further implementation across the medical colleges in the country.
For more information click on the link below:
Obese people take more sick days off work, study claims
Researchers from Vienna, studying over 122,000 individuals across Europe, have highlighted the significant impact of obesity on work absenteeism, signaling a growing concern for the labor market. These findings, presented at the European Congress on Obesity in Italy, underscore the urgent need for policymakers to prioritize initiatives promoting healthy weight maintenance.
Although the study didn’t include countries like the UK, France, Ireland, Malta, and Iceland due to insufficient data, the results from the 26 countries that were analyzed reveal that obesity increases the likelihood of taking sick leave, with the severity of obesity correlating with higher absenteeism rates. The research, partly sponsored by Novo Nordisk—a pharmaceutical company producing a weight-loss injection prescribed by the NHS—calls for immediate action.

Powered by WPeMatico

Clinical trial: New drug makes exercise, everyday tasks easier for people with common heart condition

People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England Journal of Medicine. The finding was also presented today at the European Society of Cardiology’s Heart Failure 2024 meeting in Lisbon, Portugal.

Powered by WPeMatico

Semaglutide can yield weight loss, lower heart issues for at least four years in non-diabetic adults with overweight

Two studies are being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), based on the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author group.

Powered by WPeMatico

UK survey finds ‘disgust factor’ needs to be overcome if eating insects is to become truly mainstream

New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May) finds that insect-based foods remain unappealing in the UK, and more must be done to change attitudes towards and willingness to consume insects, as a potential avenue for more sustainable food production that could reduce the carbon footprint of UK consumers.

Powered by WPeMatico

Italian study finds evidence of body dysmorphia in profile pictures of people living with obesity

New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) has found that many people who are living with obesity conceal their body in their WhatsApp profile pictures.

Powered by WPeMatico

It’s time to use TikTok to talk to young people about obesity, says researcher

There is an urgent need to harness the potential of TikTok and other social media channels to provide scientific information about obesity to young people in engaging and accessible way, the European Congress on Obesity (ECO) in Venice, Italy (12-15 May) will hear.

Powered by WPeMatico

JnJ to sell remaining 9.5 percent stake in Kenvue

Kenvue, the producer of Tylenol said on Monday that Johnson & Johnson will be selling off its remaining 9.5% stake in the company. This decision follows roughly one year after the healthcare conglomerate separated and listed its consumer health business.

Based on Kenvue stock’s last close, the offering of 182.3 million shares would be worth about $3.75 billion, according to Reuters calculation.

Kenvue’s shares were down 1.2% in premarket trading. J&J shares were largely unchanged.
J&J finalized the biggest shake-up in its 137-year history to focus on its pharmaceutical and medical devices businesses. The company in May last year sold 172.8 million shares in Kenvue to raise $3.8 billion, and lowered its stake over the next three months.
J&J will exchange its holding to Goldman Sachs and J.P. Morgan Securities for its debt, Kenvue said on Monday. Goldman Sachs, J.P. Morgan and BofA Securities are the joint lead book-running managers.
The Band-Aid maker has focused on its 15 priority brands since the spinoff and earlier this month said it would cut 4% of its global workforce.
Read also: JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn’s disease

Powered by WPeMatico

28 Km in 44 Minutes: Green corridor helps liver reach Max Saket from Fortis Hospital

New Delhi: In a profound demonstration of courage and compassion, the family of a 76-year-old road accident victim has extended the gift of life to a 30-year-old man suffering from liver cirrhosis. This act, facilitated by the skilled medical team at Fortis Hospital Shalimar Bagh, Delhi, stands as a testament to the profound impact of organ donation.

Dr Sonal Gupta, Director, and HOD Neurosurgery at Fortis Hospital Shalimar Bagh, recounted the harrowing circumstances that led to the organ donation.

According to a PTI report, a 28-km green corridor in the national capital was created from Shalimar Bagh to Saket to transport a liver to save the life of a 30-year-old man battling liver cirrhosis.

The elderly man died on May 3 and a green corridor set up to transport his liver reached Max Hospital, Saket in 44 minutes, according to a statement. 

Also Read:16.7 kgs gunny bag tumour removed from 27-year-old man’s back at FMRI Gurugram

“Despite the emergency intervention, the patient suffered brain haemorrhage due to the gravity of the head injury following the accident and multiple clots in the brain. Sadly, he could not be revived despite critical care interventions and ventilator support,” Gupta said, reports news agency ANI.

“We salute the deceased donor and deeply appreciate the generosity of his family in recognizing the value of organ donation and giving the gift of life to those in need. The seamless collaboration between our dedicated doctors and the police made this life-saving donation possible. We hope this heartwarming example inspires more people to register for organ donation and make a difference,” she added.

According to the doctors, the road accident victim after the incident was rushed to Fortis Shalimar Bagh hospital with severe head injury and oral bleeding in the first week of May. On admission, the patient was conscious, but within, half an hour he lost consciousness due to a rapidly enlarging clot in the brain. An urgent CT scan of the head revealed a large clot (Subdural Hematoma) in the brain.

An emergency brain surgery was conducted to remove the clot and bone on the right side of the skull to create extra space for the swollen injured brain. After the surgery, he was placed in the ICU on a ventilator, where a multi-disciplinary team of doctors provided intensive care. Despite vigorous efforts and medications to reduce brain swelling, the victim unfortunately succumbed to his injuries.

Amidst profound sorrow and grief, the family of the deceased displayed courage and generosity by consenting to donate their loved one’s liver to a 30-year-old man suffering from liver cirrhosis. The entire process of multi-organ retrieval surgery took around 2 hours and 35 minutes. A green corridor to transport the liver was created from Fortis Shalimar Bagh to Max Hospital, Saket covering a distance of 28.4 km in just 44 minutes.

Deepak Narang, Facility Director at Fortis Hospital Shalimar Bagh, expressed gratitude towards the donor’s family and emphasized the importance of organ donation in saving lives.

“We remain indebted to the family for their magnanimity amid grief. The clockwork precision of all internal and external medical teams made this donation a reality. This should encourage more people to come forward and get themselves registered for organ donation to save more lives,” Narang said.

According to NOTTO (National Organ and Tissue Transplant Organization), once a patient is declared brain dead, the hospital can counsel the family for organ donation. NOTTO protocol and guidelines stipulate that the treating hospital provide all details and obtain necessary clearances for a possible organ donation. In this case, the No Objection Certificate in a Medico-Legal Case (NOC-MLC) was obtained and a request for a green corridor was made.

According to an ANI report, It is estimated that almost 5 lakh Indians face organ failure every year and only 2-3 percent receive a life-saving transplant. As per data available with NOTTO, in 2022, 11 cadaver donations have been made with the successful retrieval of 30 organs in Delhi.

Every year, hundreds of people die in India, waiting for an organ transplant. Due to a lack of awareness and misconceptions, there is a shortage of organ donors, and with each passing year, the gap between the number of organs donated and the number of people waiting for transplants is growing wider. Timely cadaveric organ donation can save many lives and more people would come forth and pledge their organs if they receive more information and are educated on the benefits of organ donation.

Powered by WPeMatico

Study explores potential of oral melatonin in treating stubborn melasma

India: Melasma, a common skin condition characterized by hyperpigmentation, has long been a challenge to treat effectively. However, a recent study published in the International Journal of Dermatology has sparked hope by investigating the use of oral melatonin as a potential therapy for recalcitrant cases of melasma. The findings of this research offer a promising glimpse into a novel approach to managing this stubborn dermatological condition.

The study suggests considering oral melatonin as a well-tolerated off-label treatment for patients with recalcitrant melasma, although additional research is required.

Melasma, referred to as the “mask of pregnancy,” typically manifests as dark patches on the face, particularly on the cheeks, forehead, and upper lip. While various topical treatments and procedures exist, recalcitrant cases—those resistant to conventional therapies—present a significant clinical dilemma for dermatologists and patients alike.

The study conducted by Rashmi Sarkar, Lady Hardinge Medical College and Maulana Azad Medical College, New Delhi, India, and colleagues aimed to evaluate the efficacy of oral melatonin supplementation in reducing the severity of melasma and improving patients’ quality of life.

Melatonin, a hormone primarily known for its role in regulating sleep-wake cycles, has garnered increasing attention for its potential antioxidant and anti-inflammatory properties. Researchers hypothesized that oral melatonin supplementation could modulate melanogenesis, the process by which melanin is produced in the skin, thereby mitigating hyperpigmentation associated with melasma.

The researchers presented data from 7 patients with recalcitrant melasma treated with oral melatonin. All patients previously received treatment with either topical creams, including topical combination cream, oral tranexamic acid, or chemical peels without significant improvements.

Following a 4-week washout period, all patients received daily 3-mg melatonin tablets and used sunscreen for 12 weeks. All patients reported lightening of pigmentation, and there was an improvement from baseline in the Melasma Area and Severity Index scores.

The findings underscore the potential of oral melatonin as a safe and effective adjunctive therapy for individuals struggling with stubborn melasma. By harnessing melatonin’s antioxidant and anti-inflammatory properties, dermatologists may have a valuable tool in their arsenal for addressing this challenging condition.

While further research is needed to elucidate the optimal dosage, duration, and long-term effects of oral melatonin supplementation in melasma management, the study represents a significant step forward in expanding treatment options for patients with recalcitrant cases.

In conclusion, the investigation into the use of oral melatonin in recalcitrant melasma offers renewed hope for individuals seeking relief from this distressing skin condition. As dermatologists continue to explore innovative therapeutic approaches, oral melatonin stands out as a promising avenue for improving outcomes and enhancing the quality of life for those affected by melasma.

Reference:

Sarkar, R., Verma, B., & Mendiratta, V. Use of oral melatonin in recalcitrant melasma. International Journal of Dermatology. https://doi.org/10.1111/ijd.17201

Powered by WPeMatico